Entrez ID
Entrez Gene ID - the GENE ID in NCBI Gene database.
|
79692
|
Gene name
Gene Name - the full gene name approved by the HGNC.
|
Zinc finger protein 322 |
Gene symbol
Gene Symbol - the official gene symbol approved by the HGNC.
|
ZNF322 |
Synonyms (NCBI Gene)
Gene synonyms aliases
|
HCG12, ZNF322A, ZNF388, ZNF489 |
Chromosome
Chromosome number
|
6 |
Chromosome location
Chromosomal Location - indicates the cytogenetic location of the gene or region on the chromosome.
|
6p22.2 |
Summary
Summary of gene provided in NCBI Entrez Gene.
|
ZNF322A is a member of the zinc-finger transcription factor family and may regulate transcriptional activation in MAPK (see MAPK1; MIM 176948) signaling pathways (Li et al., 2004 [PubMed 15555580]).[supplied by OMIM, Mar 2008] |
UniProt ID |
Q6U7Q0
|
Protein name |
Zinc finger protein 322 (Zinc finger protein 322A) (Zinc finger protein 388) (Zinc finger protein 489) |
Protein function |
Transcriptional activator (PubMed:15555580). Important for maintenance of pluripotency in embryonic stem cells (By similarity). Binds directly to the POU5F1 distal enhancer and the NANOG proximal promoter, and enhances expression of both genes ( |
Family and domains |
Pfam
Accession |
ID |
Position in sequence |
Description |
Type |
PF00096
|
zf-C2H2 |
71 → 93 |
Zinc finger, C2H2 type |
Domain |
PF00096
|
zf-C2H2 |
127 → 149 |
Zinc finger, C2H2 type |
Domain |
PF00096
|
zf-C2H2 |
155 → 177 |
Zinc finger, C2H2 type |
Domain |
PF00096
|
zf-C2H2 |
183 → 205 |
Zinc finger, C2H2 type |
Domain |
PF00096
|
zf-C2H2 |
211 → 233 |
Zinc finger, C2H2 type |
Domain |
PF00096
|
zf-C2H2 |
239 → 261 |
Zinc finger, C2H2 type |
Domain |
PF00096
|
zf-C2H2 |
267 → 289 |
Zinc finger, C2H2 type |
Domain |
|
Tissue specificity |
TISSUE SPECIFICITY: Ubiquitous. Highly expressed in heart and skeletal muscle. {ECO:0000269|PubMed:15555580}. |
Sequence |
|
Sequence length |
402 |
Interactions |
View interactions
|
Causal |
Disease term |
Disease name |
dbSNP ID |
References |
Lung carcinoma |
Squamous cell carcinoma of lung |
rs1805076, rs121909071, rs121913530, rs112445441, rs121913529, rs121913535, rs121913297, rs121913279, rs104886003, rs397516975, rs11554290, rs121913364, rs121913351, rs121913369, rs121913355, rs121912470, rs121913273, rs121913281, rs121913348, rs727503093, rs121913353, rs397516890, rs397516896, rs121913378, rs397516897, rs397516977, rs397516978, rs397516979, rs397516980, rs397516981, rs397516982, rs121913240, rs17851045, rs397517086, rs121913428, rs397517094, rs397517098, rs397517106, rs121913465, rs397517108, rs397517111, rs397517112, rs397517114, rs397517116, rs1554350366, rs397517127, rs397517200, rs397517202, rs121913283, rs121913370, rs121913357, rs727503106, rs121913238, rs727503108, rs397517040, rs397516976, rs1555618025, rs1057519729, rs1584238193 View all (44 more) |
28604730 |
|
Unknown |
Disease term |
Disease name |
Evidence |
References |
Source |
Metabolic Syndrome |
Metabolic Syndrome |
|
|
GWAS |
Prostate cancer |
Prostate cancer |
Together, these results show that PRRX2 is an oncogene and might play a role in the aggressiveness of PC within the DNPC population. |
|
GWAS, CBGDA |
Breast Cancer |
Breast Cancer |
Importantly, breast cancer patients bearing PRC2 LOF mutations displayed significantly worse prognosis compared with PRC2 wild-type patients |
|
GWAS, CBGDA |
Psoriasis |
Psoriasis |
|
|
GWAS |
Dental caries |
Dental caries |
|
|
GWAS |
Insomnia |
Insomnia |
|
|
GWAS |
|
|